牛牛AI助理已提取核心訊息
On December 31, 2023, Walleye Capital LLC filed a Schedule 13G with the United States Securities and Exchange Commission, disclosing a 6.31% ownership stake in ProSomnus, Inc. This stake represents 1,103,690 shares in the company. ProSomnus, Inc. is known for its warrants, with each whole warrant exercisable for one share of common stock at $11.50 per share. The filing indicates that Walleye Capital LLC, an investment adviser based in Minnesota, holds these shares with sole voting and dispositive power. The total number of common stock shares outstanding for ProSomnus as of November 13, 2023, was 16,398,599. The Schedule 13G filing is a regulatory requirement for parties holding more than 5% of a company's stock and is not indicative of an attempt to change or influence the control of the company. The certification was signed on February 14, 2024, affirming the accuracy and completeness of the information provided.
On December 31, 2023, Walleye Capital LLC filed a Schedule 13G with the United States Securities and Exchange Commission, disclosing a 6.31% ownership stake in ProSomnus, Inc. This stake represents 1,103,690 shares in the company. ProSomnus, Inc. is known for its warrants, with each whole warrant exercisable for one share of common stock at $11.50 per share. The filing indicates that Walleye Capital LLC, an investment adviser based in Minnesota, holds these shares with sole voting and dispositive power. The total number of common stock shares outstanding for ProSomnus as of November 13, 2023, was 16,398,599. The Schedule 13G filing is a regulatory requirement for parties holding more than 5% of a company's stock and is not indicative of an attempt to change or influence the control of the company. The certification was signed on February 14, 2024, affirming the accuracy and completeness of the information provided.
2023年12月31日，Walleye Capital LLC向美國證券交易委員會提交了附表13G，披露了Prosomnus, Inc.6.31％的所有權。該股份代表該公司1,103,690股股份。ProsomNus, Inc.以其認股權證而聞名，每份完整認股權證可行使一股普通股，價格爲每股11.50美元。文件顯示，總部位於明尼蘇達州的投資顧問Walleye Capital LLC以唯一投票權和處置權持有這些股票。截至2023年11月13日，Prosomnus已發行的普通股總數爲16,398,599股。附表13G申報是監管部門對持有公司5％以上股票的各方的要求，並不表示有人試圖改變或影響公司的控制權。該認證於2024年2月14日簽署，確認了所提供信息的準確性和完整性。
2023年12月31日，Walleye Capital LLC向美國證券交易委員會提交了附表13G，披露了Prosomnus, Inc.6.31％的所有權。該股份代表該公司1,103,690股股份。ProsomNus, Inc.以其認股權證而聞名，每份完整認股權證可行使一股普通股，價格爲每股11.50美元。文件顯示，總部位於明尼蘇達州的投資顧問Walleye Capital LLC以唯一投票權和處置權持有這些股票。截至2023年11月13日，Prosomnus已發行的普通股總數爲16,398,599股。附表13G申報是監管部門對持有公司5％以上股票的各方的要求，並不表示有人試圖改變或影響公司的控制權。該認證於2024年2月14日簽署，確認了所提供信息的準確性和完整性。
有用
沒用